NCT04634669Phase 2Terminated

Open-Label Safety Study of AXS-05 in Subjects With TRD (EVOLVE)

Study sponsor: Axsome Therapeutics, Inc. · AXSM

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2022-02-18Actual
Enrollment · participants181Actual
Source updated2026-01-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Completed. After: Terminated.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview